Sign In
Buy CARM
$0.0001
+0 (+0%)
At Close: Jun 03, 2026
Why Sesen Bio Stock Bounced Back Sharply Today
05:15pm, Tuesday, 17'th Aug 2021
Some investors clearly believe all is not lost with the company's leading pipeline drug.
Federman & Sherwood Announces an Investigation into Sesen Bio
04:25pm, Tuesday, 17'th Aug 2021
OKLAHOMA CITY--(BUSINESS WIRE)-- #Biotechnology--Federman & Sherwood announces an investigation into Sesen Bio (NASDAQ: SESN). The complaint will allege violations of federal securities laws, Sections
Why Sesen Bio Stock Fell off a Cliff Monday
08:11pm, Monday, 16'th Aug 2021
The FDA dashes the company's hopes for its core pipeline drug...at least for now.
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sesen Bio, Inc. - SESN
06:20pm, Monday, 16'th Aug 2021
NEW YORK, Aug. 16, 2021 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Sesen Bio, Inc. ("Sesen Bio" or the "Company") (NASDAQ: SESN). Such investors are advised t
Sesen's (SESN) Bladder Cancer Drug Vicineum Gets CRL From FDA
12:59pm, Monday, 16'th Aug 2021
Sesen's (SESN) biologics license application filed for Vicineum to treat BCG-unresponsive non-muscle invasive bladder cancer fails to secure approval. The stock declines resultantly.
SESN Stock: Why Sesen Bio Is Getting Slammed Today
11:49am, Monday, 16'th Aug 2021
Sesen Bio (SESN) stock is taking a beating on Monday following a letter from the U.S. Food and Drug Administration (FDA). The post SESN Stock: Why Sesen Bio Is Getting Slammed Today appeared first on
Boston, Massachusetts--(Newsfile Corp. - August 16, 2021) - Block & Leviton is investigating Sesen Bio, Inc. (NASDAQ: SESN) for potential securities law violations. Investors who have lost money in th
Why Sesen Bio Shares Are Trading Lower Today
09:20am, Monday, 16'th Aug 2021
Sesen Bio Inc (NASDAQ: SESN) is trading significantly lower Monday after the U.S. Food and Drug Administration issued a Complete Response Letter for the company's bladder cancer candidate Vicineum.
Sesen Bio Stock Crashes As FDA Shoots Down Its Bladder Cancer Pitch
05:44am, Monday, 16'th Aug 2021
The FDA issued a Complete Response Letter (CRL) to Sesen Bio Inc's (NASDAQ: SESN) bladder cancer candidate Vicineum. The Company acquired the antibody-drug conjugate in the buyout of Viventia back
Sesen Bio Shares Fell Over 10% Pre-Market: Why It Happened
05:13am, Monday, 16'th Aug 2021
The shares of Sesen Bio Inc (NASDAQ: SESN) fell by over 10% pre-market. This is why it happened.
What Did the Stock Market Do Today, Aug. 13? 3 Big Stories to Catch Up On.
05:12pm, Friday, 13'th Aug 2021
So what did the stock market do today? All eyes were on a wacky story about GRNV stock, a little-known SPAC that skyrocketed.
Boston, Massachusetts--(Newsfile Corp. - August 13, 2021) - Block & Leviton is investigating Sesen Bio, Inc. (NASDAQ: SESN) for potential securities law violations. Investors who have lost money in
Sesen Bio Shares Suddenly Fell Over 85% Late Afternoon: Why It Happened
03:48pm, Friday, 13'th Aug 2021
The shares of Sesen Bio (Nasdaq: SESN) suddenly fell over 85% during intraday trading in the late afternoon today. This is why it happened.
Sesen Bio's stock rocked on heavy volume after shock FDA decision on BLA for cancer treatment
03:33pm, Friday, 13'th Aug 2021
Shares of Sesen Bio Inc. SESN, -63.34% was rocked for a more than 75.4% loss on massive volume in afternoon trading Friday, after the company focused on cancer treatments shocked investors by saying i
What's Next For Sesen Bio Stock: A Technical Analysis
03:11pm, Friday, 13'th Aug 2021
Sesen Bio Inc. (NASDAQ: SESN) shares traded higher Friday on anticipation of the announcement of the company's expected FDA decision. The decision was made that the company's Biologics License Appli
